These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
331 related articles for article (PubMed ID: 11267753)
1. Leishmania infantum-specific IgG, IgG1 and IgG2 antibody responses in healthy and ill dogs from endemic areas. Evolution in the course of infection and after treatment. Solano-Gallego L; Riera C; Roura X; Iniesta L; Gallego M; Valladares JE; Fisa R; Castillejo S; Alberola J; Ferrer L; Arboix M; Portús M Vet Parasitol; 2001 Apr; 96(4):265-76. PubMed ID: 11267753 [TBL] [Abstract][Full Text] [Related]
2. Specific IgG1 and IgG2 antibody responses of dogs to Leishmania infantum and other parasites. Deplazes P; Smith NC; Arnold P; Lutz H; Eckert J Parasite Immunol; 1995 Sep; 17(9):451-8. PubMed ID: 8552413 [TBL] [Abstract][Full Text] [Related]
3. Specific IgG1 and IgG2 antibody and lymphocyte subset levels in naturally Leishmania infantum-infected treated and untreated dogs. Bourdoiseau G; Bonnefont C; Hoareau E; Boehringer C; Stolle T; Chabanne L Vet Immunol Immunopathol; 1997 Oct; 59(1-2):21-30. PubMed ID: 9437823 [TBL] [Abstract][Full Text] [Related]
4. Comparative analysis of the Leishmania infantum-specific antibody repertoires and the autoantibody repertoires between asymptomatic and symptomatic dogs. Chaabouni A; Boubaker Elandoulsi R; Mhadhbi M; Gharbi M; Sassi A Vet Parasitol; 2018 Sep; 261():9-17. PubMed ID: 30253856 [TBL] [Abstract][Full Text] [Related]
5. Dynamics of Leishmania-specific immunoglobulin isotypes in dogs with clinical leishmaniasis before and after treatment. Rodríguez A; Solano-Gallego L; Ojeda A; Quintana J; Riera C; Gállego M; Portús M; Alberola J J Vet Intern Med; 2006; 20(3):495-8. PubMed ID: 16734080 [TBL] [Abstract][Full Text] [Related]
6. Cell mediated immunity and specific IgG1 and IgG2 antibody response in natural and experimental canine leishmaniosis. Leandro C; Santos-Gomes GM; Campino L; Romão P; Cortes S; Rolão N; Gomes-Pereira S; Riça Capela MJ; Abranches P Vet Immunol Immunopathol; 2001 May; 79(3-4):273-84. PubMed ID: 11389961 [TBL] [Abstract][Full Text] [Related]
7. Early reduction of Leishmania infantum-specific antibodies and blood parasitemia during treatment in dogs with moderate or severe disease. Solano-Gallego L; Di Filippo L; Ordeix L; Planellas M; Roura X; Altet L; Martínez-Orellana P; Montserrat S Parasit Vectors; 2016 May; 9(1):235. PubMed ID: 27160317 [TBL] [Abstract][Full Text] [Related]
8. Serological and parasitological follow-up in dogs experimentally infected with Leishmania infantum and treated with meglumine antimoniate. Riera C; Valladares JE; Gállego M; Aisa MJ; Castillejo S; Fisa R; Ribas N; Carrió J; Alberola J; Arboix M Vet Parasitol; 1999 Jul; 84(1-2):33-47. PubMed ID: 10435789 [TBL] [Abstract][Full Text] [Related]
9. Changes in the concentration of anti-Leishmania antibodies in saliva of dogs with clinical leishmaniosis after short-term treatment. Cantos-Barreda A; Escribano D; Cerón JJ; Tecles F; Bernal LJ; Martínez-Subiela S Vet Parasitol; 2018 Apr; 254():135-141. PubMed ID: 29656998 [TBL] [Abstract][Full Text] [Related]
10. Follow-up of Leishmania infantum naturally infected dogs treated with allopurinol: immunofluorescence antibody test, ELISA and Western blot. Vercammen F; Fernandez-Perez FJ; del Amo C; Alunda JM Acta Trop; 2002 Dec; 84(3):175-81. PubMed ID: 12443795 [TBL] [Abstract][Full Text] [Related]
11. Immunoglobulin G and E responses in various stages of canine leishmaniosis. Iniesta L; Gállego M; Portús M Vet Immunol Immunopathol; 2005 Jan; 103(1-2):77-81. PubMed ID: 15626463 [TBL] [Abstract][Full Text] [Related]
12. Value of Western blotting in the clinical follow-up of canine leishmaniasis. Fernández-Pérez FJ; Méndez S; de la Fuente C; Cuquerella M; Gómez MT; Alunda JM J Vet Diagn Invest; 1999 Mar; 11(2):170-3. PubMed ID: 10098690 [TBL] [Abstract][Full Text] [Related]
13. Hepatic fibropoiesis in dogs naturally infected with Leishmania (Leishmania) infantum treated with liposome-encapsulated meglumine antimoniate and allopurinol. Castro RS; de Amorim IFG; Pereira RA; Silva SM; Pinheiro LJ; Pinto AJW; Azevedo EG; Demicheli C; Caliari MMV; Mosser DM; Michalick MSM; Frezard FJG; Tafuri WL Vet Parasitol; 2018 Jan; 250():22-29. PubMed ID: 29329619 [TBL] [Abstract][Full Text] [Related]
14. TLR-2 and TLR-4 transcriptions in unstimulated blood from dogs with leishmaniosis due to Leishmania infantum at the time of diagnosis and during follow-up treatment. Montserrat-Sangrà S; Alborch L; Ordeix L; Solano-Gallego L Vet Parasitol; 2016 Sep; 228():172-179. PubMed ID: 27692322 [TBL] [Abstract][Full Text] [Related]
15. Relationships between specific antibody responses and clinical signs of dogs living in Tunisian endemic areas of canine leishmaniasis caused by Leishmania infantum. Mhadhbi M; Chaabouni A; Bouabid C; Sassi A Acta Trop; 2021 Jun; 218():105906. PubMed ID: 33775627 [TBL] [Abstract][Full Text] [Related]
16. Anti-Leishmania humoral and cellular immune responses in naturally infected symptomatic and asymptomatic dogs. Cardoso L; Schallig HD; Cordeiro-da-Silva A; Cabral M; Alunda JM; Rodrigues M Vet Immunol Immunopathol; 2007 May; 117(1-2):35-41. PubMed ID: 17321602 [TBL] [Abstract][Full Text] [Related]
17. IgG subclass responses in a longitudinal study of canine visceral leishmaniasis. Quinnell RJ; Courtenay O; Garcez LM; Kaye PM; Shaw MA; Dye C; Day MJ Vet Immunol Immunopathol; 2003 Feb; 91(3-4):161-8. PubMed ID: 12586479 [TBL] [Abstract][Full Text] [Related]
18. Idiotype expression of IgG1 and IgG2 in dogs naturally infected with Leishmania infantum. Iniesta L; Gállego M; Portús M Vet Immunol Immunopathol; 2007 Oct; 119(3-4):189-97. PubMed ID: 17631971 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of meglumine antimoniate after administration of a multiple dose in dogs experimentally infected with Leishmania infantum. Valladares JE; Riera C; Alberola J; Gállego M; Portús M; Cristòfol C; Franquelo C; Arboix M Vet Parasitol; 1998 Feb; 75(1):33-40. PubMed ID: 9566092 [TBL] [Abstract][Full Text] [Related]
20. Changes in serum anti-Leishmania antibody concentrations measured by time-resolved immunofluorometric assays in dogs with leishmaniosis after treatment. Cantos-Barreda A; Escribano D; Martínez-Subiela S; Pardo-Marín L; Segarra S; Cerón JJ Vet Immunol Immunopathol; 2018 Apr; 198():65-69. PubMed ID: 29571520 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]